Yuki Gosei Kogyo Co., Ltd. (JP:4531)
:4531
Top Page
Yuki Gosei Kogyo Co., Ltd.
(4531)
Select Model
Select Model
Rating:50Neutral
Price Target:
¥402.00
▲(26.81% Upside)
Action:DowngradedDate:03/24/26
The score is held back primarily by weak cash-flow quality (negative free cash flow and inconsistent cash conversion) and bearish technicals (below key moving averages with negative MACD). Improved profitability and a generally stable balance sheet provide support, while valuation is neutral with a modest dividend yield.
Positive Factors
Revenue Growth
Multi-year revenue expansion to ~¥15.1B indicates durable demand across pharmaceuticals, agriculture and industrial customers. Steady top-line growth supports scale advantages, customer relationships and recurring sales that underpin long-term product development and margin recovery.
Negative Factors
Negative Free Cash Flow
Persistent negative free cash flow despite improved operating cash in 2025 (~¥2.14B) indicates heavy investment or working-capital strain. Continued FCF deficits increase reliance on the balance sheet, limit organic funding for growth, and raise execution risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Multi-year revenue expansion to ~¥15.1B indicates durable demand across pharmaceuticals, agriculture and industrial customers. Steady top-line growth supports scale advantages, customer relationships and recurring sales that underpin long-term product development and margin recovery.
Read all positive factors
Yuki Gosei Kogyo Co., Ltd. (4531) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.73B
Dividend Yield2.97%
Average Volume (3M)39.67K
Price to Earnings (P/E)23.5
Beta (1Y)0.99
Revenue Growth9.92%
EPS Growth-27.64%
CountryJP
Employees290
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)3.41
Shares Outstanding21,974,000
10 Day Avg. Volume32,460
30 Day Avg. Volume39,673
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)0.44
Price to Sales (P/S)0.38
P/FCF Ratio-4.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Yuki Gosei Kogyo Co., Ltd. Business Overview & Revenue Model
Company Description
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, n...
Yuki Gosei Kogyo Co., Ltd. Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
62
Positive
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.86B | 15.13B | 12.93B | 12.84B | 12.36B | 11.09B |
| Gross Profit | 3.19B | 3.23B | 3.26B | 3.05B | 2.36B | 1.82B |
| EBITDA | 1.93B | 2.23B | 1.93B | 1.56B | 1.18B | 1.27B |
| Net Income | 708.00M | 896.00M | 776.00M | 556.00M | 248.00M | 288.00M |
Balance Sheet | ||||||
| Total Assets | 27.35B | 27.29B | 24.75B | 22.35B | 21.38B | 21.25B |
| Cash, Cash Equivalents and Short-Term Investments | 1.05B | 973.00M | 588.00M | 1.14B | 1.86B | 1.26B |
| Total Debt | 9.06B | 8.51B | 6.87B | 5.58B | 5.54B | 6.10B |
| Total Liabilities | 14.31B | 14.18B | 12.31B | 10.87B | 10.38B | 10.30B |
| Stockholders Equity | 13.03B | 13.11B | 12.43B | 11.48B | 11.00B | 10.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.20B | -1.37B | -490.00M | 1.40B | -208.00M |
| Operating Cash Flow | 0.00 | 2.14B | 388.00M | 668.00M | 1.79B | 352.00M |
| Investing Cash Flow | 0.00 | -3.25B | -1.89B | -1.24B | -442.00M | -648.00M |
| Financing Cash Flow | 0.00 | 1.50B | 948.00M | -158.00M | -772.00M | 106.00M |
Yuki Gosei Kogyo Co., Ltd. Technical Analysis
Neutral
317.00
Price Trends
448.30
Negative
375.87
Positive
324.64
Positive
Market Momentum
-10.44
Positive
39.56
Neutral
35.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4531, the sentiment is Neutral. The current price of 317 is below the 20-day moving average (MA) of 436.15, below the 50-day MA of 448.30, and below the 200-day MA of 324.64, indicating a neutral trend. The MACD of -10.44 indicates Positive momentum. The RSI at 39.56 is Neutral, neither overbought nor oversold. The STOCH value of 35.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4531.
Yuki Gosei Kogyo Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥16.11B | 8.02 | ― | 3.89% | -3.00% | -29.83% | |
77 Outperform | ¥7.59B | 0.81 | ― | 1.96% | 8.43% | 2.99% | |
74 Outperform | ¥203.81B | 8.69 | ― | 4.09% | 1.69% | 0.94% | |
71 Outperform | ¥13.09B | 9.40 | ― | 1.81% | 9.07% | ― | |
65 Neutral | ¥81.28B | 17.82 | ― | 0.67% | 10.18% | -14.36% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | ¥8.73B | 23.47 | ― | 2.97% | 9.92% | -27.64% |
* Basic Materials Sector Average
JP:4531
Yuki Gosei Kogyo Co., Ltd.
405.00
136.00
50.56%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
3,350.00
688.69
25.88%
JP:4041
Nippon Soda Co., Ltd.
3,640.00
758.30
26.31%
JP:4093
Toho Acetylene Co., Ltd.
457.00
100.06
28.03%
JP:4366
Daito Chemix Corporation
393.00
182.67
86.85%
JP:4970
Toyo Gosei Co., Ltd.
9,780.00
4,117.21
72.71%
Yuki Gosei Kogyo Co., Ltd. Corporate Events
Yuki Gosei Kogyo Posts Higher Sales but Sharp Profit Decline and Cuts Full-Year Outlook
Jan 30, 2026
Yuki Gosei Kogyo reported non-consolidated net sales of ¥11,017 million for the nine months ended December 31, 2025, a modest 1.6% increase year on year, but saw profitability weaken sharply, with operating income down 41.5% to ¥364 mill...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.